Yearly Archives: 2026
-
MiYOSMART iQ Halts Myopia Progression in Nearly All Young Children in Landmark Trial
Posted on August 15, 2026 by Kameron in News.https://www.optometrytimes.com/view/arvo-2026-miyosmart-iq-demonstrates-myopia-control-in-children-as-young-as-aged-4 A new clinical trial presented at ARVO 2026 by HOYA Vision Care and The Hong Kong Polytechnic University is turning heads in myopia management. The randomized controlled trial enrolled 196 school children in Hong Kong, ages 4 to 12, and the results were striking: the new spectacle lens design halted clinically relevant myopia progression […]
Continue Reading... Comments Off on MiYOSMART iQ Halts Myopia Progression in Nearly All Young Children in Landmark Trial -
Lab-Grown Retinal Cells Offer New Hope for Treating Vision Loss
Posted on July 14, 2026 by Kameron in News.https://pratt.duke.edu/news/lab-grown-retinal-cells/ A Window into the Body There’s an old saying that the eyes are windows into the soul, and it’s more literal than you’d think, the retina connects directly to the brain, technically making your eyes part of the central nervous system. That’s part of what makes a new advance from Duke University so exciting. […]
Continue Reading... Comments Off on Lab-Grown Retinal Cells Offer New Hope for Treating Vision Loss -
Inflammation and Eye Health
Posted on February 8, 2026 by Scott in News.https://www.cedars-sinai.org/newsroom/common-bacteria-discovered-in-the-eye-linked-to-cognitive-decline Common Eye Bacteria Linked to Cognitive Decline: What Optometrists and Patients Should Know Emerging research continues to highlight the close connection between eye health and overall brain health. A recent study from Cedars-Sinai Medical Center has uncovered a potential link between a common bacterium found in the eye and cognitive decline associated with Alzheimer’s disease, offering new insight […]
Continue Reading... Comments Off on Inflammation and Eye Health -
New Lacrifill Canalicular Gel release for Dry Eye Disease
Posted on February 8, 2026 by Scott in News.https://www.optometrytimes.com/view/nordic-group-bv-announces-commercial-launch-of-lacrifill-canalicular-gel Introducing Lacrifill Canalicular Gel: A Novel Dry Eye Therapy Now Commercially Available in the U.S. Nordic Group B.V., through its U.S. subsidiary Nordic Pharma, has officially launched Lacrifill® Canalicular Gel, a new interventional dry eye treatment now commercially available in the United States. This innovative therapy offers eyecare professionals a targeted approach to managing dry eye disease (DED) by […]
Continue Reading... Comments Off on New Lacrifill Canalicular Gel release for Dry Eye Disease